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Interactions of Chrysotile and
Benzopyrene in a Human Cell Culture
Systems
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K. M. Schenck,t H. A. 1. Newman,t P. D. Lipetz*
and J. R. Millettet
The risk of lung cancer related to asbestos exposure has been shown to increase disproportion-
ately by cigarette smoking, suggesting a synergistic effect. Differing lengths of NIEHS chrysotile
with benzopyrene [B(a)P, B(e)P] (organic by-products of combustion) were applied on normal human
fibroblasts (cell line Cl) to test for cytotoxicity (survival determined by colony-forming efficiency),
binding of benzopyrene to DNA, and the production ofbenzopyrene metabolites.
At concentrations of 100pg/mL, NIEHS short chrysotile was more cytotoxic than NIEHS interme-
diate chrysotile(3% and 17% survival,respectively), B(a)Pand B(e)Pconcentrations uptoandinclud-
ing 10pM were not cytotoxic. Simultaneous application of NIEHS short chrysotile with B(a)P or
B(e)P did not decrease survival synergistically. On the contrary, application ofB(a)Psimultaneously
with NIEHS intermediate chrysotile resulted in increased survival over that of intermediate chryso-
tile alone (25% and 17% survival, respectively). There were low levels ofB(a)P bound to DNA in the
presence of NIEHS short chrysotile or NIEHS intermediate chrysotile. Measurable levels of
B(a)P-DNA adducts were formed both in the absence and in the presence of each size of NIEHS
chrysotile. However, there was no strong indication of a perturbation of the level of DNA-B(a)P
binding following simultaneous administration of increasing levels of asbestos in addition to 1 JM
hydrocarbon. The asbestos had no demonstrable influence on the level of B(a)P metabolism during
the 24-hr period following simultaneous exposure of asbestos and hyrdocarbons. In addition, the
B(a)P-deoxynucleoside adducts formed both in the presence of 1 mgdmL short chrysotile and in its
absence, as determined by co-chromatography on HPLC with standards formed by the reaction of
the (+ )anti-benzo(a)pyrenediol epoxide at the exocyclic amino group of deoxyriboguanosine (NI).
Introduction
Human exposure to fibrous silicates is associated
with the development of asbestosis (1-3) in a large
percentage of asbestos workers (4). The risk of lung
cancer related to asbestos exposure has been shown
to increase disproportionately due to cigarette
smoking, suggesting a synergistic effect. In one re-
ported 5-year span, malignancies are 1.5 times
greater and lung cancer 2.6 times more prevalent in
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those exposed to asbestos than nonexposed individ-
uals (2). Asbestos workers who smoke cigarettes
run an even higher risk of developing lung cancer,
more than 90 times the normal rate of the general
nonexposed, nonsmoking population and 30 times
greater than asbestos workers who do not smoke
(5). A similar study by McMillan et al.(6) in England
also showed a significantly higher prevalence of as-
bestos-related lesions in asbestos workers who
smoked or were ex-smokers,than in nonsmokers.
Idiopathic interstitial lung disease can be due to
environmental toxins, i.e., chemicals and/or particu-
lates. However, the primay consequences of asbes-
tos exposure is fibrosis (7, 8). End-stage interstitial
lung disease is frequently manifested as pulmonary
fibrosis. Since pulmonary fibrosis is the characteris-
tic lesion assocated with asbestosis, we investi-STEPHENSETAL.
gated the effects of asbestos with and without ben-
zopyrene in a normal human dermal fibroblast (CI)
cell culture system.
Chrysotile, a serpentine asbestos, was chosen for
the study since it is the most common type of asbes-
tos used in the United States. Two sizes of chryso-
tile, short and intermediate, mean length and width
of 6.8 ,Mm by 0.16 Hm and 21.0 ,um by 0.17 ,um, respec-
tively, as determined by scanning electron micro-
scopy (9) were supplied by the National Institute of
Environmental Health Sciences (NIEHS). We inves-
tigated the effects of the chrysotile using the follow-
ing parameters: (1) cytotoxicity with and without si-
multaneous application of B(a)P or B(e)P; (2) metabol-
ism of B(a)P in the presence and absence of chryso-
tile; and (3) binding of the B(a)P to DNA in the pres-
ence and absence of the chrysotile.
Materials and Methods
Cell Culture Techniques
A normal human dermal fibroblast cell line (CI)
was established in the laboratory of Dr. R. W. Hart
(Department of Radiology, The Ohio State Univer-
sity). This cell line was derived from explants of nor-
mal white male neonate foreskin. Tissue was
minced while being digested with 0.01% trypsin
(Worthington), then incubated in a 370C water bath
for 30 min. The trypsin was inactivated by adding
10 times the volume of Eagle's Minimum Essential
Medium (EMEM) supplemented with 1 mM sodium
pyruvate, 2 mM glutamine, 1.5 x nonessential
amino acids and 1.5 x BEM vitamins (GIBCO), 10%
fetal bovine serum (FBS) (FLOW) plus 100 U/mL
penicillin, 100 jAg/mL streptomycin and 100 ,ug/mL
fungizone (Squibb). Explants were plated into Corn-
ing 60 mm tissue culture dishes and incubated in a
humidified, 5°h CO2 atmosphere at 370C until cells
covered at least 80% of the bottom of the dish.
Stock cultures were maintained in supplemented
EMEM without antibiotics or fungizone. All cul-
tures were routinely checked for bacteria, fungi,
virus and Mycoplasma sp. by the Department of Pa-
thology's Clinical Microbiology Laboratory (The
Ohio State University) and/or The Ohio Department
of Health Laboratories.
Stock cultures were serially (1:2) passaged at
95% confluence. Cultures were washed twice with
phosphate-buffered saline (PBS) to remove residual
EMEM. Trypsin (0.01%) was added to the cultures
and allowed to act at room temperature (270C) until
the cells were detached from the substrate (5-15
min). Supplemented EMEM was then added at ten
times the volume of the trypsin to inactivate the
trypsin's proteolytic activity. This mixture was tri-
turated three times to insure a monodispersed cell
suspension. A 0.5 mL portion of cell suspension was
mixed with 0.5 mL of trypan blue (0.4% trypan blue
solution in normal saline, GIBCO) and counted on a
hemocytometer, to determine cell viability and cell
concentration. The remainder of the cell suspension
was plated in Corning tissue culture flasks and sup-
plemented EMEM was added. Cultures were incu-
bated in the same manner as detailed above; cells
were fed every third day until 95% confluent (ap-
proximately 1 week).
Cytotoxicity Methods
Normal human dermal fibroblasts (CI) were
plated at a density of 500 cells/100 mm Corning dis-
posable tissue culture Petri dish in supplemented
EMEM. Cells were allowed to attach for 6 hr before
application of the asbestos and/or the benzopyrene.
Asbestos concentrations ranged from 0.1 ,g/mL to 1
mg/mL (concentrations were made by serial dilu-
tion) and the benzopyrene concentrations ranged
from 0.1 jM to 10 «>M. Particulates were applied in
the EMEM and the benzopyrene was applied in di-
methyl sulfoxide-1 methanol (4:1, v/v). Twenty repli-
cas were used for each test concentration, and each
experiment was repeated three times. After 24 hr
of exposure (incubation at 37°C and in a humidified
5% CO2195% air environment) the dishes were
washed twice with 10 mL of PBS, and 10 mL fresh
supplemented EMEM was added to each plate. A 5
mL portion of supplemented EMEM was added to
the experimental cultures weekly until control colo-
nies were at least 5 mm in diameter. Colonies were
then fixed with Modified Carnoy's Fixative (metha-
nol-glacial acetic acid, 3:1 v/v), rinsed three times
with tap water and allowed to dry overnight. After
drying, colonies were stained with saturated Crys-
tal Violet. Colonies were counted electronically by
using an Artek Model 880 dark-field counter.
Binding and Metabolism of Benzo(a)pyrene
Culture Technique& Normal human fibroblasts
(CI) were plated at 3.3 x 104 cells/cm2 in EMEM
plus 10% fetal bovine serum (FBS). Cells were fed
with EMEM plus 10% FBS every third day until
they reached confluence. At confluence, varying
concentrations of NIEHS short chrysotile were ap-
plied simultaneously with 1 M 3H-B(a)P previously
purified to greater than 98% radiochemical purity.
EMEM plus 10% FBS was incubated with 3H-B(a)P
without cells as an oxidized control or was frozen
immediately as a nonoxidized control.
Samples were incubated for 24 hr as previously
described. Following incubation, the medium was
aspirated and saved for the metabolite study. Cells
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were then washed three times with PBS to remove
remaining radioactivity. A 5 mL portion of lysis so-
lution (8M urea, 0.1M PBS, 10/ SDS and 0.01M
EDTA) was applied and allowed to stand for 5 min,
dishes were scraped and the lysate aspirated. PBS
(5 mL) was used to remove residual lysate and
pooled.
Samples were sealed in serum bottles and frozen
at - 200C until analysis.
DNA Isolation. The DNA was isolated by hy-
droxyapatite chromatography as described in detail
previously (10). Briefly, the lysates were adsorbed
onto 0.5 mg of Bio-Rad HTP-DNA grade hydroxy-
apatite and the gel was washed three times with 10
mL of 8 M urea plus 0.01 M sodium phosphate (pH
6.8) followed by 10 washes of 10 mL of 0.12 M so-
dium phosphate buffer (pH 6.8). The DNA was
eluted from the gel by two washes with 1.5 mL of
0.48 M sodium phosphate (pH 6.8). The pooled DNA
washes were extracted four times with equal vol-
umes of water-saturated n-butanol to assure that all
free, noncovalently bound radioactivity was re-
moved. Subsequently, an aliquot of the DNA prepa-
ration was removed for hydrocarbon-DNA binding
determination by analysis of radioactivity (liquid
scintillation counting following acid hydrolysis, in 6
mL of Amersham PCS II on an LKB model 1216
Rack-Beta) and DNA quantitation via the 3,5-di-
aminobenzoic acid fluorescence reaction (11).
B(a)P-DNA Adduet Analysis The purified DNA
samples were hydrolyzed to the deoxyribonucleo-
side level enzymatically as described previously in
detail (10). The resulting B(a)P-DNA adducts were
analyzed on Zorbax-ODS (4.6 x 250 mm) columns
employing a 50 to 80% methanol-in-water linear
gradient over 30 min at a flow rate of 1 mL/min on a
Varian Model 5000 instrument. Sixty 0.5-mL frac-
tions were collected with an ISCO model 1800 frac-
tion collector. The effluent was monitored at 330 nm
with a Vari-chrom UV detector and for fluorescence
(excitation = 330 nm, emission > 389 nm) with a
Schoeffel model GM 970. Each fraction was ana-
lyzed by liquid scintillation counting following addi-
tion of 5 mL Amersham PCS II. The vials were ana-
lyzed and the data plotted with the LKB model
1216 in the DPM-PLOT mode.
MetabolismAnalysi. The extent of B(a)P metab-
olism was estimated by the method of DePierre et
al. (12), modified as indicated. Briefly, 1 mL of me-
dium was treated with equal volumes of 80% etha-
nol and 0.5 N NaOH; the resulting mixture was
extracted and 2.5 mL of cyclohexane. The
unmetabolized B(a)P in the organic layer was
analyzed by liquid scintillation counting follow-
ing removal of water by treatment with 1 g of
anhydrous Na2SO4.
Results
NIEHS short chrysotile was more toxic to normal
human dermal fibroblasts than NIEHS intermediate
chrysotile at concentrations greater than 100 ,g/mL
(Fig. 1). Concentrations less than or equal to 10 ,g/
mL ofboth the short and intermediate chrysotile re-
sulted in similar minimal effects.
Application of either B(a)P or B(e)P [a noncarcino-
genic analog of B(a)P] produced no cytotoxic ef-
fect (Fig. 2). Application of NIEHS short chrysotile
simultaneously with either B(a)P (Fig. 3) or B(e)P
(Fig. 4) did not enhance the cytotoxic effects of the
asbestos alone. However, application of NIEHS in-
termediate chrysotile simultaneously with B(a)P
(Fig. 3) or B(e)P (Fig. 4) seemed to diminish the cyto-
toxic effects of the fiber.
Disregarding the benzopyrenes and pooling all
the data by concentration (Table 1), at concentra-
tions of 1 iAg/mL or less there were no significant
differences between the cytotoxicity of the short or
intermediate chrysotile, whereas at concentrations
of 10 lAg/mL and 100 ,ug/mL there was a significant
difference between the two types of chrysotile. A
dose of 1000,g/mL of either type of chrysotile is ex-
tremely toxic (Figs. 1, 3 and 4), and there is no sig-
nificant difference (Table 1).
To determine which main effects and interactions
were significant a factorial analysis of variance was
performed on the cytotoxicity data. The main ef-
fects determined to be significant at p < 0.01 were
length (short versus intermediate chrysotile), group
(i.e., short, intermediate, short plus B(e)P, etc.) and
concentration. Interactions of length versus group
and length versus concentration also proved to be
significant at p < 0.01 (Table 2). An aftertest, New-
man-Keules, was used to determine the level of sig-
nificance of specific interactions (Tables 1 and 3).
Specific groups versus length were analyzed (Table
3). It was determined that the following groups
were significantly different from each other at p <
0.05: intermediate chrysotile versus intermediate
plus B(a)P or intermediate plus B(e)P, short chryso-
tile plus B(a)P versus intermediate plus B(a)P, and
short plus B(e)P versus intermediate plus B(e)P.
Table 4 details the effect of varying doses of
NIEHS short chrysotile on B(a)P-DNA binding. No
clear pattern of enhanced binding with increasing
levels of fiber emerged in these studies. Less than
10% of the benzo(a)pyrene was metabolized by the
fibroblasts at all asbestos concentrations.
The B(a)P-deoxyribonucleoside adducts from the
control (0 pg/mL chrysotile) and highest dose (1000
,ugImL) groups are compared in Figure 5. In both
cases the major B(a)P-DNA adduct, fractions 27-32,
cochromatographs with the standard prepared from
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FIGURE 1. Cytotoxicity on 24-hr treatment of CI with NIEHS chrysotile.
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FIGURE 3. Cytotoxicity on 24-hr treatment of CI with simultaneous application of
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Table 1. Newman Keules: concentration versus length.a
Mean survival fractionb
Concentration, Intermediate Short
pg/mL chrysotile chrysotile Difference t Test
0.1 85.90 90.28 4.38 3.74
1.0 74.52 79.24 4.72 1.26
10.0 47.10 25.26 21.84 5.84*
100.0 23.32 1.62 21.70 5.80*
1000.0 13.96 1.18 12.78 3.42
aRelationship between the concentration and length of chrysotile as determined by cytotoxicity atp < 0.01.
bMean of the survival fraction summed across groups (disregarding chemical applied with the chrysotile).
*Significant atp < 0.01.
Table 2. Factorial analysis of variance.
Degree of F Significance
freedom Test levelp
Length 1 15.95 <0.001
Group 2 5.54 <0.01
Concentration 4 193.34 <0.001
Length x Group 2 5.91 <0.01
Length x Concentration 4 6.31 <0.001
Group x Concentration 8 1.27 N.S.
Length x Group x Concentration 8 0.61 N.S.
Table 3. Newman Keules: group versus length.a
t test value (confidence interval)b
Intermediate Plus B(a)P Plus B(e)P Short Plus B(a)P
Intermediate
Plus B(a)P 4.79 (0.01)
Plus B(e)P 6.20 (0.01) 1.41 (N.S.)
Short 0.24 (N.S.)
Plus B(a)P 3.37 (0.05) 1.18 (N.S)
Plus B(e)P 6.64 (0.01) 0.69 (N.S.) 1.87 (N.S.)
aRelationship between the group and length of concentration as determined by cytotoxicity.
bt test value, with confidence interval in parentheses (i.e., p<0.01); N.S. = not significant.
the reaction of (+ )7fl,8a-dihydroxy-9a,10a-epoxy-
7,8,9,10-tetrahydroBP (BPDE I) and deoxyguano-
sine. This adduct has previously been confirmed as
7R-N2-10p-[7p,8a,9a-trihydroxy-7,8,9,10-tetrahydro-
BP]yl)deoxyguanosine (7R-BPDE I-dG) (11). The en-
antiomeric 7S-N241lOf-[7p,8a,9a-trihydroxy-7,8,9,10-
tetrahydroBP]yl)deoxyguanosine (7S-BPDE I-G)
eluted slightly earlier (fractions 24-27) in this system
and was observed only in the control cultures (Fig.
5A). This was interesting, since previous studies us-
ing cultured human bronchus and bladder explants
without fiber have always produced the 7S-PBDE I-
dG adduct (11, 13). The minor adduct eluting in frac-
tions 21-24 in both control (Fig. 5A) and treated (Fig.
5B) cultures was unidentified, but by analogy with
previous work (14-16) may be a BP-deoxycytidine
adduct. Previous work with cultured human bron-
chus and bladder (11, 13, 17) and human colon (18)
have been consistently given at least one deoxygua-
Table 4. Benzopyrene binding to DNA
in the presence of asbestos.
Short chrysotile
concentrations,pg/mL
0
0.1
1.0
10.0
100.0
1000.0
BP binding
pmole/mole
deoxyribonucleotide (±t S.D.)a
1.73± 0.50
3.09± 0.68
1.55± 0.21
2.17+ 0.28
1.92+ 0.38
2.40 + 0.35
aN = 3 (the number ofreplicate samples).
nosine adduct of the BPDE II ([+ ]-7p,8a-dihydroxy-
9P,103-epoxy-7,8,9,10-tetrahydroBP) which eluted in
fractions 33-35 in this system. This adduct may be
present in small amounts in the controls but is not
evident in the treated group. Finally, with these
cultures, as with cultured human bronchus and blad-
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FIGURE 5. Benzo(a)pyrene adducts to DNA in the presence and absence of NIEHS
short chrysotile as determined by HPLC: (A) control cultures4(B) treated cultures.
7R-BPDE I-dG = 7R-N2-(10p-[73,8a,9a-trihydroxy-7,8,9,10-tetrahydroBP]yl)deoxygua-
nosine; 7S-BPDE I-dG = 7S-N2-(10p-[7p,8a,9a-trihydroxy-7,8,9,10-tetrahydroBPI
yl)deoxyguanosine; 7(R/S)-BPDE II-dG = 7(R/S)-N'-(10a-[713,8a,9a-trihydroxy-7,8,9,10-
tetrahydroBP)yl]deoxyguanosine.
der explants (13), there was no evidence of B(a)P-de-
oxyadenosine adducts which elute in later fractions
(38-43). The early polar peak (fractions 8-12) is also
unidentified at present. This peak was also found in
incubations of human explant cultures with B(a)P
(11).
Discussion
Most investigators studying the toxicity of asbes-
tos have used nonhuman material (19-24) or nonfi-
broblast human cells (25-29). Reiss et al. (28) com-
pared human embryonic intestine-derived cells (I-
407) with adult rat liver-derived cells (ARL-6).
Chrysotile was more toxic to the 1407 cells than the
ARL-6 cells, and MCE-1 cells (mouse derived) were
less sensitive than the ARL-6. In these systems
they have demonstrated that fiber dimensions are
correlated with toxicity (20, 21, 30, 31). In the human
dermal fibroblast system, we have shown that the
NIEHS short chrysotile is the most cytotoxic.
NIEHS amosite has a higher aspect ratio than the
short chrysotile and a lower aspect ratio than the
intermediate chrysotile, but the amosite is far less
toxic than either the intermediate or the short
chrysotile (32).
Benzopyrene in our system does not show a syn-
ergism when applied simultaneously with either in-
termediate or short chrysotile. Also, benzopyrene in
its unactivated state does not seem to be toxic to
normal human fibroblasts. Human epithelial cells
are more capable of metabolizing B(a)P to its ulti-
mate carcinogenic form than are human fibroblasts
(33). Our observations are in general agreement in
that very low levels of BPDE adducts are formed
by CI fibroblasts. Also, B(a)P-DNA (deoxyguano-
sine) formed in the hamster tracheal epithelial sys-
tem chromatographed to the same place as the CI
control peaks (15).
Thus, consistent with earlier results using
NIEHS intermediate chrysotile (34, 35), the simul-
taneous addition of NIEHS short chrysotile and
B(a)P did not enhance, in a dose-dependent manner,
the metabolism and subsequent DNA binding of the
hydrocarbon in human fibroblasts. However, when
7S-BPDE
20
DPN 00
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00
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the B(a)P-DNA adducts formed in the presence of 1
mg/mL NIEHS short chrysotile were compared by
HPLC analysis with those generated in the absence
of the fiber, the relative amounts of the various
enantiomeric B(a)P-deoxyribonucleoside adducts ap-
peared to be altered. Most notably, in the case of
the adducts generated in the presence of the fiber,
in marked contrast to the controls, the 7S-BPDE I-
dG adduct was clearly missing. We are currently in-
vestigating this observation in more detail to see if
this apparent perturbation of the stereochemistry
of the B(a)P-activation-DNA-binding processes is al-
tered in a dose-related manner. At present, the sig-
nificance ofthis observation, ifany, is unclear.
From our results a number of conclusions are
suggested. (1) Available reactive surface area may
play a major role in determining mineral cytotoxic-
ity; for instance, on a weight/weight basis, short
chrysotile has a greater surface area than interme-
diate chrysotile and therefore has more reactive
sites than the intermediate chrysotile. (2) Masking
of these reactive sites (such as Mg+2) by certain or-
ganic compounds could possibly decrease the min-
eral's cytotoxicity. (3) The low levels of aryl hydro-
carbon hydroxlase in the human fibroblasts could be
responsible for the low levels of B(a)P metabolism
das).
The statistical analysis was done by the Biometrics Group,
Department of Preventive Medicine at The Ohio State Uni-
versity. The graphics were done in cooperation with Dr.
Richard Fertel, Department of Pharmacology at The Ohio
State University.
Although the research described in this article has been
funded wholly or in part by the United States Environmental
Protection Agency through contract or grant CR807284 to
The Ohio State University, it has not been subjected to the
Agency's required peer and policy review and therefore does
not necessarily reflect the views of the Agency and no official
endorsement should be inferred.
REFERENCES
1. Selikoff, I. J., Hammond, E. C., and Churg, J. Asbestos
exposure, smoking and neoplasia. J. Am. Med. Assoc. 204:
106-112 (1968).
2. Selikoff, I. J. and Churg, J., (Eds.). Biological Effects of
Asbestos. Ann. New York Acad. Sci., Vol. 132, Pt. 1, New
York Academy ofScience, 1965.
3. Selikoff, I. J., and Hammond, E. C. (Eds.), Health Hazards
of Asbestos Exposure. Ann. New York Acad. Sci. 330
(1979).
4. Hammond, E. C., and Selikoff, I. J. Relation of cigarette
smoking to the risk of death of asbestos-associated dis-
ease. In: Biological Effects of Asbestos (P. Bogovski,
V. Timbell, J. C. Gilson and J. C. Wagner, Eds.), IARC
Sci. Publ. No. 8 IARC, Lyon, 1973, pp. 312-317.
5. Anonymous. Medical news. J. Am. Med. Assoc. 243 (3)
211-219 (1980).
6. McMillan, G. H. G., Pethybridge, R. J., and Sheers, G. Ef-
fect of smoking on attack rates of pulmonary and pleural
lesions related to exposure to asbestos dusts. Brit. J. Ind.
Med. 37: 268-272 (1980).
7. Becklake, M. R. Asbestos-related diseases of lung and
other organs: their epidemiology and implications for clin-
ical practice. Am. Rev. Resp. Dis. 114: 187-277 (1976).
8. Gee, J. B. Cellular mechanisms in occupational lung dis-
ease. Chest 78: 384-387 (1980).
9. Campbell, W. J., Huggins, C. W., and Wylie, A. B. Chemi-
cal and physical characterization of amosite, chrysotile,
crocidolite, and nonfibrous tremolite for oral ingestion
studies by the National Institute of Environmental Health
Sciences. Report of Investigation R. I. 8452, U.S. Dept. of
Interior, Bur. of Mines, 1972.
10. Stoner, G. D., Daniel, F. B., Schenck, K. W., Schut, H. A.
J., Goldblatt, P. J., and Sandwisch, D. W. Metabolism and
DNA binding of benzo(a)pyrene in cultured human blad-
der and bronchus. Carcinogenesis 3: 195-201 (1982).
11. Kissane, J. M., and Robins, E., The fluorometric measure-
ment of deoxyribonucleic acid in animal tissue with
special reference to the central nervous system. J. Biol.
Chem. 223: 184-188 (1958).
12. DePierre, J. W., Moron, M. S., Johannesen, K. A. M., and
Ernster, L. A reliable, sensitive and convenient radioac-
tive assay for benzopyrene monooxygenase. Anal. Bio-
chem. 63: 470-484 (1975).
13. Daniel, F. B., Stoner, G. D., Sandwisch, D. W., Schenck,
K. M., Hoffman, C. A., Schut, H. A. J., and Patrick, J. R.
Interspecies comparisons of benzo(a)pyrene and DNA-ad-
duct formation in cultured human and animal bladder and
tracheobronchial tissues. Cancer Res., in press.
14. Brown, H. S., Jeffrey, A. M., and Weinstein, I. B. Forma-
tion of DNA adducts in lOT 1/2 mouse embryo fibroblasts
incubated with benzo(a)pyrene or dihydrodiol oxide
derivatives. Cancer Res. 39: 1673-1677 (1979).
15. Eastman, A., Mossman, B. T., and Bresnick, E. Formation
and removal of benzo(a)pyrene adducts of DNA in ham-
ster tracheal epithelial cells. Cancer Res. 41: 2605-2610
(1981).
16. Jennette, K. W., Jeffrey, A. M., Blobstein, S. H., Beland,
F. A., Harvey, R. G., and Weinstein, I. B. Nucleoside ad-
ducts from the in vitro reaction of benzo(a)pyrene-7,8-di-
hydrodiol-9,10-oxide or benzo(a)pyrene-4,5-oxide with nu-
cleic acids. Biochemistry 16: 932-938 (1977).
17. Autrup, H., Welfald, F. C., Jeffrey, A. M., Tate,
H., Schwartz, R. D., Trump, B. F., and Harris, C. C. Me-
tabolism of benzo(a)pyrene by cultured tracheobronchial
tissues from mice, rats, hamsters, bovines and humans.
Int. J. Cancer 25: 293-300 (1980).
18. Autrup, H., Harris, C. C., Trump, B. F., and Jeffrey, A. M.
Metabolism of benzo(a)pyrene and identification of the
major benzo(a)pyrene-DNA adducts in cultured human
colon. Cancer Res. 38: 3689-3696 (1978).
19. Allison, H. D. Experimental methods-cell and tissue
culture: effects of asbestos particles on macrophages,
mesothelial cells and fibroblasts. In: Biological Effects of
Asbestos (P. Bogovski, V. Timbell, J. C. Gilson and J. C.
Wagner, Eds.), IARC Sci. Publ., International Agency for
Research on Cancer, No. 8, Lyon, 1973, pp. 89-93.
20. Harrington, J. S. The biological effects of mineral fibers,
especially asbestos, as seen from in vitro and in vivo stud-
ies. Ann. Anat. Pathol. 21: 155-198 (1976).
21. Huang, S. L. Amosite, chrysotile and crocidolite asbestos
are mutagenic in Chinese hamster lung cells. Mutat. Res.
68: 265-274(1979).
22. Mossman, B. T., Craighead, J. E., and MacPherson, B. V.
Asbestos-induced epithelial changes in organ cultures of
hamster trachea: inhibition by retinyl methly ether. Sci-
ence 207: 311-313 (1979).ASBESTOS-BENZOPYRENE INTERACTIONS 265
23. Neugut, A. I., Eisenberg, D., Silverstein, M., Pulkrabek,
P., and Weinstein, I. B. Effects of asbestos on epithelioid
cell lines. Environ. Res. 17: 256-265 (1978).
24. Thomson, R., Kilroe-Smith, T. A., and Webster, I. The ef-
fect of asbestos-asbestos-associated metal ions on the
binding of benzo(a)pyrene to macromolecules in vitro. En-
viron. Res. 15: 309-319 (1978).
25. Beck, E. G. Interaction between fibrous dust and cells in
vitro. Ann. Anat. Pathol. 21: 227-236 (1976).
26. Chamberlain, M., and Brown, R. C. The cytotoxic effects
of asbestos and other mineral dust in tissue culture cell
lines. Brit. J. Exptl. Pathol. 59: 183-189 (1978).
27. McLemore, T. L., Roggli, V., Marshall, M. V., Lawrence,
E. C., Greenberg, S. D., and Stevens, P. M. Comparison of
phagocytosis of uncoated versus coated asbestos fibers by
cultured human pulmonary alveolar macrophages. Chest
(July 1 Suppl.) 39S-42S (1981).
28. Reiss, B., Solomon, S., Weisburger, J. H. and Willams,
G. M. Comparative toxicities of different forms of
asbestos in a cell culture assay. Environ. Res. 22: 109-129
(1980).
29. Reiss, B., Millette, J. R., and Williams, G. M. The activity
of environmental samples in a cell culture test for asbes-
tos toxicity. Environ. Res. 22: 315-321 (1980).
30. Pott, F., Friedrichs, K.-H., and Huth, F. Results of animal
experiments concerning the carcinogenic effect of fibrous
dusts and their interpretation with regard to the carcino-
genesis in humans. Zbl. Bakt. H. Abt. Orig. B162: 467-505
(1976).
31. Stanton, M. F., and Wrench, C. Mechanisms of mesotheli-
oma induction with asbestos and fibrous glass. J. Natl.
Cancer Inst. 48: 797-821 (1972).
32. Joseph, L. B., Chang, M. J. W., Hart, R. W., and
Stephens, R. E. Differential absorption of macromolecules
to mineral fibers in vitro. Paper presented at 16th Mid-
west Mtg. American Chemical Society, Lincoln, NE, 1980.
33. Fox, C. H., Selkirk, J. K., Price, F. M., Croy, R. G., San-
ford, K. K., and Fox-Cottler, M. Metabolism of benzo(a)py-
rene by human epithelial cells in vitro. Cancer Res. 35:
3351-3357 (1975).
34. Daniel, F. B., Beach, C. A. and Hart, R. W. Asbestos-
induced changes in the metabolism of polycylic aromatic
hydrocarbons in human fibroblast cultures. In: The In
Vitro Effects of Mineral Dusts (R. C. Brown, M. Chamber-
lain, R. Davies, and I. P. Gormley), Academic Press, New
York-London, 1980, pp. 255-262.
35. Hart, R. W., Daniel, F. B., Kindig, 0. R., Beach, C. A.,
Joseph, L. B., and Wells, R. C. Elemental modifications
and polycyclic aromatic hydrocarbon metabolism in hu-
man fibroblasts. Environ. Health Perspect. 34: 59-68
(1980).